Welcome, please sign in
Follow DJO on Facebook Follow DJO on Twitter


Register with DJO to receive personalized updates.

If you're already a
member, please sign in.

Advanced tubercular ampiginous-like choroiditis
Sep 2, 2021
Volume 27, Number 3
Michael J. Ammar, MD | Wills Eye Hospital, Mid Atlantic Retina, Uveitis and Retinal Disease Service, Pennsylvania
Luv G. Patel, MD | Wills Eye Hospital, Mid Atlantic Retina, Uveitis and Retinal Disease Service, Pennsylvania
Matthew R. Starr, MD | Wills Eye Hospital, Mid Atlantic Retina, Uveitis and Retinal Disease Service, Pennsylvania
James P. Dunn, MD | Wills Eye Hospital, Mid Atlantic Retina, Uveitis and Retinal Disease Service, Pennsylvania
A 68-year-old white man presented at Wills Eye Hospital with chronic decreased vision in both eyes. His social history was significant for prior incarceration. Dilated fundus examination of both eyes demonstrated extensive chorioretinal scarring and fibrosis (A, B). Widefield imaging fundus autofluoresence demonstrated extensive areas of hypoautofluoresence (C, D). Infectious and inflammatory workup was significant for positive purified protein derivative and QuantiFERON-TB Gold testing. The patient was subsequently diagnosed with tubercular ampiginois-like choroiditis. In conjunction with the infectious disease service, he underwent treatment with four-drug (rifampin, isoniazid, pyrazinamide, ethambutol) therapy and oral prednisone. He was eventually transitioned to immunomodulatory therapy with methotrexate and stabilized with counting fingers visual acuity in the right eye and 20/100 in the left eye.

Back to DJO images